Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v10-FR | Version v1-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2023-10-07 | 2023-03-17 |
| Drug Identification Number | 02224860 | 02224860 |
| Brand name | SOFRAMYCIN NASAL SPRAY | SOFRAMYCIN NASAL SPRAY |
| Common or Proper name | Soframycin | Soframycin |
| Company Name | SEARCHLIGHT PHARMA INC | SEARCHLIGHT PHARMA INC |
| Ingredients | GRAMICIDIN FRAMYCETIN SULFATE PHENYLEPHRINE HYDROCHLORIDE | GRAMICIDIN FRAMYCETIN SULFATE PHENYLEPHRINE HYDROCHLORIDE |
| Strength(s) | 0.05MG 12.5MG 2.5MG | 0.05MG 12.5MG 2.5MG |
| Dosage form(s) | SPRAY | SPRAY |
| Route of administration | NASAL NASAL | NASAL NASAL |
| Packaging size | 15ml | 15ml |
| ATC code | R01AB | R01AB |
| ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
| Reason for shortage | Shortage of an active ingredient. | Shortage of an active ingredient. |
| Anticipated start date | 2023-02-15 | 2023-02-15 |
| Actual start date | ||
| Estimated end date | 2023-10-30 | 2023-05-15 |
| Actual end date | 2023-10-06 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |